{"transactions":[{"id":4613466,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":51792,"kind":"person","name":"Chin Peter Scott","position":1,"cik":"0002124755","reported_name":"Chin Peter Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-09T20:44:33.000Z","date":"2026-09-04","kind":"sale","planned":false,"acquired":false,"shares":1654,"price":22.29,"value":36867.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.28 to $22.29 per share. Upon request by the Commission staff, the Issuer, or a\nsecurity holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 142,845 Unvested RSU's"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 1,790 shares acquired under the ESPP Purchase on June 1, 2026."}],"balance_after":204538,"source":{"system":"sec-edgar","filing":"0002124755-26-000007","document":"wk-form4_1788986671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2124755/000212475526000007/wk-form4_1788986671.xml","form_type":"4"}}]}